chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a consumer, the mother of a 17 year old female. Medical history and concomitant medications were not specified. On 15-JUL-2016, the female received a fifth dose of GARDASIL intramuscularly. It was uncertain whether the vaccine was GARDASIL or GARDASIL 9. It was unspecified when the female received the other four vaccinations. No adverse effect was reported. Additional information is not expected as the mother refused to provided contact information.
No adverse event; Bivalent doses administered after the BUD to; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to) and NO ADVERSE EVENT (No adverse event) in a 61-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 13-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to).    No concomitant medication was provided by reporter. No treatment medication was provided by reporter.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with Gardasil (lot# unknown) 0.5 mL injection and fainted. Medical attention was sought.  At the time of reporting it was unknown if the patient had recovered.  No additional information was provided.  No further information is available.  This is one of two reports from the same source.
had both doses of the covid vaccine, has not had her period since receiving the covid vaccine; This is a spontaneous report from a contactable consumer reporting for herself. A 44-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EP1533), dose 1 via an unspecified route of administration, administered in Arm Left on 28Mar2021 11:30 (at the age of 44-year-old) as single dose and dose 2 via an unspecified route of administration, administered in Arm Left on 18Apr2021 11:30 (Batch/Lot Number: EW0101) (at the age of 44-year-old) as dose 2, single for covid-19 immunization. Medical history included ongoing diabetes mellitus from 2017, and liver transplant from 2019, patient took mediations to suppress her immune system. She had a low immune system. Patient had a family history of diabetes, both her parents had diabetes. Patient was on several medications for her liver transplant. Patient did not take any other vaccines within four weeks, prior to covid-19 immunization. On an unknown date in 2021, it was reported that, caller has already had both doses of the covid vaccine, has not had her period since receiving the covid vaccine, and caller wants to know if that was a normal thing. Her last period was 16Mar2021. The events did not result in Emergency Room/Physician Office visit. Relevant Tests reported as none. The outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Post vax, pt developed an injection site reaction characterized by a 6 inch by 3 inch area of redness and swelling. This is 1 of 2 pts from this facility who experienced this event following receipt of vax. Additional information states pt recovered
This spontaneous report as received from a pharmacist refers to a 72 year old female patient. The patient's medical history and concurrent conditions were unknown. On 21-AUG-2016, the patient was vaccinated with ZOSTAVAX lot # M019645, single dose: 0.65 ml, via subcutaneous in the left arm (expiration date was not reported). Information regarding concomitant medication was not provided. On 21-AUG-2016, the patient developed lesions and one bump at the injection site, then on 29-AUG-2016, the patient experienced rash in both arms the number of lesions were 3-5. At the time of the report, the outcome of the injection site mass and rash were unknown. The causality between ZOSTAVAX and the adverse events was unknown. Additional information is expected.
right knee was swollen; back hurt; their left eye was hurting; their hands were achy; swollen in their feet; super exaggerated pains in their body; they were sore, they were achy, their hands were achy; very tired feeling; whole arm was like it was dead; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (whole arm was like it was dead), JOINT SWELLING (right knee was swollen), BACK PAIN (back hurt), OCULAR DISCOMFORT (their left eye was hurting) and PAIN IN EXTREMITY (their hands were achy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroidectomy. Concurrent medical conditions included Rheumatoid arthritis, Backache, unspecified, Blood pressure abnormal and Type 2 diabetes mellitus.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced MOBILITY DECREASED (whole arm was like it was dead). On 26-Feb-2021, the patient experienced JOINT SWELLING (right knee was swollen), BACK PAIN (back hurt), OCULAR DISCOMFORT (their left eye was hurting), PAIN IN EXTREMITY (their hands were achy), PERIPHERAL SWELLING (swollen in their feet), PAIN (super exaggerated pains in their body), MYALGIA (they were sore, they were achy, their hands were achy) and FATIGUE (very tired feeling). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MOBILITY DECREASED (whole arm was like it was dead), JOINT SWELLING (right knee was swollen), BACK PAIN (back hurt), OCULAR DISCOMFORT (their left eye was hurting), PAIN IN EXTREMITY (their hands were achy), PERIPHERAL SWELLING (swollen in their feet), PAIN (super exaggerated pains in their body), MYALGIA (they were sore, they were achy, their hands were achy) and FATIGUE (very tired feeling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported taking unspecified blood pressure, type 2 diabetes, and thyroid medications.
This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a 56-year-old female patient who received SHINGRIX for prophylaxis. On 5th December 2018, the patient received the 1st dose of SHINGRIX. In December 2018, less than a month after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the patient experienced nausea, fever and general body pain. On 25th December 2018, the outcome of the pain in arm was recovered/resolved. On an unknown date, the outcome of the nausea, fever and general body pain were recovered/resolved. It was unknown if the reporter considered the pain in arm, nausea, fever and general body pain to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a Medical Assistant. The patient experienced severe pain in her left arm. The patient also experienced nausea, body aches, and fever that lasted for approximately 2 days. The reporter did not consent to follow up. The reporter did not want any follow up.
R/T/TDAD 11/13/09 patient presented L upper arm, c/o itching and redness @ injection site approximately 2" diameter. Reddened area, warm to touch T 97 degrees, P 68, B/P 112/72
Day of the vaccine the body felt different, when home the arm was in pain for a day or two. By Friday even there was a headache and on Saturday it was worse. The doctor friend said to take Tylenol and lay down. On Sunday the left ear was swelling and the left side of the face was swelling. The doctor friend continued to recommend the Tylenol. The following Wednesday the sister took her to the hospital. The hospital said the face was disfigured and told her she has Bell Parsley.  She will need to see an ear specialist. Her eyes were affecting her.
SICKNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced sickness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sickness was not reported. This report was non-serious.
The evening after receiving vaccine mom states pt. would not nap or sleep through the night for four days. The most she would sleep was 30 min. at a time, had insomnia. Otherwise well, no symptoms.
Sitting in car talking with my wife, she all of the sudden noticed I had slurred speech and drooping mouth. She asked me to get out of the car and when I did, I was unsteady and could not balance on my feet. She called for help. I was taken to emergency center.
8/22/05 broke out with rash, bumpy with erythematous base. Possible chicken pox. Treated with acyclovir 600mg qid x 5d.
redness and tenderness at site of injection, fever and headache started about 24 hours after vaccine received. Pt is started on Keflex.
I95.9 HYPOTENSION 4/20/2021 ANEMIA I95.9 HYPOTENSION 4/20/2021 RIGHT KNEE JOINT PAIN I95.9 HYPOTENSION 4/20/2021 ANEMIA
On June 10, 1999 the pt developed raised spots on her lower back and around the waist. The following day, a few spots appeared on the back of her legs. Gradually, she developed more spots. It was indicated that the spots were raised, itchy, but they never really crusted and didn't weep. Treatment with diphenhydramine hydrochloride was initiated and was followed with a visit to a dermatologist and pediatrician.
Red rash on arm very itchy.  Had it on 2/13, 14. 15.  Nothing on 2/16-18 then it came back on 2/19 to present.
Breakthrough case admission after 2 vaccines Moderna 9/22/21 Lot# 048F21A;  Moderna 10/20/21 Lot# 017f21A
SWELL (PLACE OF INJECTION); TIREDNESS; HEADACHE; NAUSEA; MUSCLE PAIN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced swell (place of injection), tiredness, headache, nausea, and muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tiredness, headache, nausea, swell (place of injection) and muscle pain was not reported. This report was non-serious.
Weakness, flushing of skin, shortness of breath, Hydration with 1 liter of normal saline, Decadron IV, Benadryl IV and Pepcid IV.
Droopy; Feeling minimal pain now; Drugged; Nausea; Possible Fever; Real bad chills; Pain in left Shoulder and Neck; Couldn't stop Shaking; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Droopy), TREMOR (Couldn't stop Shaking), PAIN (Feeling minimal pain now), FEELING ABNORMAL (Drugged) and ARTHRALGIA (Pain in left Shoulder and Neck) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A, 030M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, the patient experienced TREMOR (Couldn't stop Shaking), ARTHRALGIA (Pain in left Shoulder and Neck) and CHILLS (Real bad chills). On an unknown date, the patient experienced ASTHENIA (Droopy), PAIN (Feeling minimal pain now), FEELING ABNORMAL (Drugged), NAUSEA (Nausea) and PYREXIA (Possible Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Droopy), TREMOR (Couldn't stop Shaking), PAIN (Feeling minimal pain now), FEELING ABNORMAL (Drugged), ARTHRALGIA (Pain in left Shoulder and Neck), NAUSEA (Nausea), CHILLS (Real bad chills) and PYREXIA (Possible Fever) outcome was unknown.        Concomitant medication included Thyroid medication.   This case was linked to MOD-2021-298768, MOD-2021-298769 (Patient Link).
hard swollen "knot" on thier shoulders; hard swollen mass on thier shoulders; Information has been received from a physician via a company representative, referring to two male patients of unknown ages. The patients' medical history, concurrent conditions and concomitant therapies were not reported.   On an unknown dates, the patients were vaccinated with doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (anatomical location, administration route, lot numbers and expiration dates were not reported) for prophylaxis.         On an unspecified date (reported as 3-4 weeks after the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) administration), the two patients who are brothers both developed hard swollen "knot" on their shoulders with no evidence of infections.  The outcome of the hard swollen "knot" on their shoulders was unknown.  The casuality assessment between the aforementioned event and the vaccination with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was not provided.
Had flu shot 10/5/11. Woke up this morning with red cheeks & warmth & achiness in both cheeks. Had cortisone shot at MD office same day too. Instructed to notify MD.
Tested positive for covid after receiving the first dose of the vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid after receiving the first dose of the vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 immunisation.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid after receiving the first dose of the vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid after receiving the first dose of the vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-016742 (Patient Link).
Two days after my first vaccine both of my ears started ringing (tinnitus). I scheduled an appointment with an ENT he attempted to treat the tinnitus with low does of prednisone and amitriptyline after speaking to my OBGYN, since I was 9 weeks pregnant. The prednisone helped to take the edge off during the 2 weeks that I took it but never resolved the problem. The amitriptyline did not help at all. Before the prednisone or when the prednisone was done. My ears have been continuously ringing since September 29th 2021.
After 3rd dose: Muscle soreness at injection site; Muscle soreness at injection site and some surrounding muscles (neck, shoulder).; Patient was administered with Booster dose 3, BNT162B2; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration on 21Oct2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. It was not reported if the patient received any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3428) via an unspecified route of administration on 12Jan2021 (at the age of 51-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3428) via an unspecified route of administration on 02Feb2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 22Oct2021, after third dose, the patient experienced muscle soreness at injection site and some surrounding muscles which included neck, shoulder. Soreness was present at the time of report, even 24 hours after injection. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event muscle soreness at injection site and some surrounding muscles which included neck, shoulder was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Patient had preexisting excema all over body (arms, legs, back, stomach, face). Was told my his doctor that it could just be due to the weather or food allergies. Ruled out weather after seeing happen year round. We have been keeping a close eye on food he intakes to see what could possibly set it off, and have found nothing. After reciving his HEP A shot on 02/05/2015, that evening the immunization spot had the worst eczema we had seen, very scaly and dry. As well as all his other eczema getting worse than it was the days before. We got him on a steroid cream, but does not seem to be working. After lots of research we think that the vaccines may have led to his severe eczema in the first place.
Fatigue, slept for 24 + hours, fever, body aches, nausea and vomitting.
Patient was scheduled to receive his second monovalent vaccine.  The patient was given a Bivalent vaccine instead.  No adverse reactions noted by the parents.  Pfizer was notified and provided the information that no further Bivalent vaccine should be given at this time.  Reached out to our medication safety officer who suggested that the patient come in for his second monovalent 2-3 months.  Parents were contacted and left a message to call back the office.  No return call has been made.
Started having shortness of breath; Took a home COVID-19 test and it was positive. Rested until I felt better.
Inflamed and painful lymph nodes in armpits, on breast bone and on ribs the the same side of body as injection.
This case was reported by a nurse via call center representative and described the occurrence of fainting in a 16-year-old female patient who received BEXSERO (batch number 166801, expiry date 31st May 2018. Concomitant products included MENACTRA. On 22 March 2017 15:00, the patient received the 1st dose of BEXSERO (intramuscular) .5 ml. On 22nd March 2017, less than a day after receiving BEXSERO, the patient experienced confusion and headache. On 22nd March 2017 15:10, the patient experienced fainting, dizziness and head injury. On 22nd March 2017, the outcome of the fainting, dizziness and head injury were recovered/resolved. On an unknown date, the outcome of the confusion and headache were unknown. The reporter considered the fainting and dizziness to be possibly related to BEXSERO. It was unknown if the reporter considered the head injury, confusion and headache to be related to BEXSERO. Additional details were reported as follows: This case was reported by a medical assistant. The healthcare provider reported that the patient received MENACTRA in the left deltoid and a few seconds later received BEXSERO in the right deltoid. Approximately 10 minutes after vaccination, the patient was checking out in the waiting room and she fainted and hit the back of her head. The healthcare provider reported that the physician rushed out to examine the patient and the symptoms resolved shortly after. The patient was reportedly confused and had a headache after the event. The reporter stated that the patient stated, after she recovered, that after the vaccine was given she felt dizzy but did not mention it to the nurse or doctor at the time. During the collection of the adverse event the nurse stated they have had other patients that felt dizzy or had headaches, but  never fainted like this patient. The nurse asked them if they had reported those events and they replied no because in the past they were told that those events were most likely not related to the vaccine. The nurse was not sure who gave that information to them. No additional information was provided at the time of reporting regarding any other possible adverse events in other patients.
Long covid symptoms recurred--fatigue, cough, joint aches, body aches, herpes outbreak, back pain, anxiety, shortness of breath. Brain fog, forgetfulness, paper cuts became very infected for 2 weeks each, vaginal infections, I felt like my immune system had shut down, or become so overly active, it couldn't protect me against very minor infections.  I did not have brain fog, brain inflammation before the vaccines.
Vaccines administered 11/26/07. That night area was red. By next am red patch had enlarged and pt would complain of pain when it was bumped/touched. Tx-ice cont. OTC analgesics f/u 2 wk if not resolved